本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

9.52
+0.30003.25%
成交量:118.38万
成交额:1,129.03万
市值:5.15亿
市盈率:-5.78
高:9.90
开:9.40
低:9.30
收:9.22
数据加载中...
2021/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/09/21

重要事件披露

8-K - Current report
2021/09/09

重要事件披露

8-K - Current report
2021/08/10

重要事件披露

8-K - Current report
2021/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/30

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/06/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/09

重要事件披露

8-K - Current report
2021/05/14

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/03/19

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/09

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/09

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/05

重要事件披露

8-K - Current report